In conclusion, in a family with OI, we identified a COL1A1 mutation known to be responsible for OI, and further identified a novel second mutation in the COL5A1 C-terminal propeptide domain in patients with OI and EDS. Here, COL5A1 is linked to Ehlers-Danlos syndrome.